SSTR2 promoter hypermethylation is associated with the risk and progression of laryngeal squamous cell carcinoma in males.
about
SHISA3 Promoter Methylation Is a Potential Diagnostic and Prognostic Biomarker for Laryngeal Squamous Cell Carcinoma.NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population.International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
P2860
SSTR2 promoter hypermethylation is associated with the risk and progression of laryngeal squamous cell carcinoma in males.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
SSTR2 promoter hypermethylatio ...... amous cell carcinoma in males.
@ast
SSTR2 promoter hypermethylatio ...... amous cell carcinoma in males.
@en
type
label
SSTR2 promoter hypermethylatio ...... amous cell carcinoma in males.
@ast
SSTR2 promoter hypermethylatio ...... amous cell carcinoma in males.
@en
prefLabel
SSTR2 promoter hypermethylatio ...... amous cell carcinoma in males.
@ast
SSTR2 promoter hypermethylatio ...... amous cell carcinoma in males.
@en
P2093
P2860
P1433
P1476
SSTR2 promoter hypermethylatio ...... amous cell carcinoma in males.
@en
P2093
Chongchang Zhou
Shiwei Duan
Xiaoying Chen
Zhisen Shen
P2860
P2888
P356
10.1186/S13000-016-0461-Y
P577
2016-01-22T00:00:00Z
P5875
P6179
1024675319